Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05259319
Title Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) (IMMUNOs-SBRT)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Centre Georges Francois Leclerc
Indications

head and neck carcinoma

lung non-small cell carcinoma

renal cell carcinoma

urinary bladder cancer

Therapies

Atezolizumab + Tiragolumab

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST